Opendata, web and dolomites

CoaguPOC

SMART POINT-OF-CARE DEVICE FOR SELF-PATIENT MANAGEMENT OF THE ORAL ANTICOAGULANT THERAPY

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 CoaguPOC project word cloud

Explore the words cloud of the CoaguPOC project. It provides you a very rough idea of what is the project "CoaguPOC" about.

once    permitting    67    events    savings    healthcare    people    monitor    regular    approximately    point    saving    hospital    anticoagulants    blood    world    center    led    prevent       correct    home    pocket    therapy    potentially    lethal    clinics    small    reductions    monitoring    2nd    usually    intensifying    western    market    uk    first    dosing    self    unnecessary    population    anticoagulant    leads    clots    visits    narrow    50    quality    550    inhibit    coagulometers    death    ready    prescribed    drugs    systemic    life    confirm    toxic    dosage    smart    single    patient    anti    thrombotic    million    oral    nursing    hospitals    therapeutic    adjustment    12    pressure    service    care    usual    frequent    made    oat       annually    hemorrhages    10    coagulant    thrombosis    instance    chronic    seek    lab    mere    window    coagupoc    families    give    adverse    patients    risk    levels    substantial    strokes    tests    constant    device    18   

Project "CoaguPOC" data sheet

The following table provides information about the project.

Coordinator
RELOGABLE S.L. 

Organization address
address: C/ POLLENSA 2 -DESPACHO 4.1
city: LAS ROZAS DE MADRID
postcode: 28290
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Project website http://www.relogable.com/projects.html
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.4. (Active ageing and self-management of health)
2. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT))
3. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
4. H2020-EU.3.1.6. (Health care provision and integrated care)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2017
 Duration (year-month-day) from 2017-05-01   to  2017-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    RELOGABLE S.L. ES (LAS ROZAS DE MADRID) coordinator 50˙000.00

Map

 Project objective

The goal we seek in CoaguPOC project is to develop a “ready to the market” smart point-of-care device for self-patient management of the Oral Anticoagulant Therapy (OAT). OAT is a long-term or even chronic therapy necessary to inhibit the formation of potentially lethal blood clots in patients with high risk of thrombosis; e.g. strokes, the 2nd single largest cause of death in the world. Approximately 2% of the population are prescribed long-term oral anticoagulants, meaning that more than 10-12 million people are treated in Western Europe.

OAT therapy needs regular tests to confirm correct dosage levels because the drugs have a narrow therapeutic window and small changes in systemic changes can give rise to adverse toxic effects. Tests are usually made once a month in a nursing service at the hospital or care center. The constant increase on the number of anti-coagulant patients (around 10% annually) is highly intensifying pressure and cost on the healthcare resources required to monitor, prevent and manage adverse events.

The use of point-of-care coagulometers at home for self-monitoring may avoid unnecessary visits to hospitals or clinics while permitting more frequent monitoring and timely adjustment of anticoagulant dosing to avoid adverse events. The OAT self-management leads to important reductions on adverse events, as thrombosis (reduction by 50%), major hemorrhages (12%), death (18%) and thrombotic events (67%) as compared to ‘usual care‘. It also has a substantial impact on the quality of life of patients and their families, and important cost savings on the healthcare system. For instance, in UK a mere increase of 5% improved in average therapeutic range, led to a reduction of 550 strokes per year and associated cost saving of around €12,000 per patient.

CoaguPOC aims bringing to the market the first low-cost and smart point of care device for OAT patients to self-monitor and self-manage their chronic condition. We aim to bring the lab to your pocket

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "COAGUPOC" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "COAGUPOC" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.4.;H2020-EU.2.1.1.;H2020-EU.2.3.1.;H2020-EU.3.1.6.)

CLINICOVERY (2018)

CLINICOVERY, a versatile, high quality, environmental-friendly, easy to use e-Clinical solution for clinical research

Read More  

ImmuneHunter (2017)

Bioinformatics platform for profiling of health: allowing early and accurate detection of multiple diseases simultaneously

Read More  

SensUS (2018)

SensUS: A non-invasive and quantitative ultrasound (QUS) device for an objective monitoring of the childbirth labour process.

Read More